ISRG - Intuitive Surgical, Inc. Pick

A mystical forest shrouded in fog, bathed in the soft, warm glow of the orange morning dawn. The ethereal atmosphere of the misty woods creates a sense of tranquility and mystery, as the first light of day gently pierces through the fog, illuminating the towering trees. The scene evokes a peaceful, otherworldly beauty, perfect for those who seek the quiet serenity of nature at its most enchanting.

Research brief

Oct 06, 2026 Afternoon

05:40 PM UTC

Intuitive Surgical, Inc. ISRG low

ISRG

Conf. Low

Pick Pr. $406.17

Stop Pr. $387.49

Curr. Pr. $405.00

Change -0.29%

Rem. Days 7

Summary

Recommendation: ISRG, Momentum, Low confidence, for exactly seven calendar days. The edge is verified stock-specific recovery, not newly disclosed clinical revenue: September 8–October 5 gained 16.08%, versus XLV 0.53% and SPY 1.41%. finance.yahoo Decider judgment: continuation is actionable, but weak participation makes the edge fragile.
Preserved research quote: $405.075012 at October 6, 14:40 ET. Latest publication observation: $405.239990 at 15:07 ET, not a claimed fill. finance.yahoo Applying unchanged decider assumptions yields +0.5604% research expected net return, or +0.5376% at the newer quote; these are calculations, not source-reported forecasts.
The benchmark comparison is modest: the decider estimates SPY at +0.20% net over the matched seven days. Research expected excess is +0.3604 percentage points; deducting the decider's 1.65-point uncertainty gives −1.2896 points. The adverse stock scenario loses 1.0881%. These estimates pass the positive absolute-return gate before uncertainty, not a claim of robust alpha.
Risk is wider than the visible intraday base. The $404.04 research base remains unbroken in the checked completed bars, but the authored stop is $387.50. finance.yahoo The decider's $384.50 conditional stop-exit estimate explicitly allows delayed confirmation and gaps; neither stop level guarantees a fill.
VST is the best confirmed alternative, not a hard rejection. Its repaired research forecast earns +0.3047% net and ranks below ISRG after uncertainty. The independent 14:55 publication comparison retained that order, while incomplete trigger/legal checks kept COIN and DELL conditional. No separate VOO-versus-cash allocation decision was triggered.

Why Now

The verified edge is price persistence. October 5's 3.71% rebound recovered the completed 20- and 50-day averages, following a 16.08% September 8–October 5 advance. That period's excess was 15.55 points over healthcare and 14.67 points over SPY, distinguishing the observed move from simple sector beta. However, the stock remains below its $446.4751 completed 200-day average. finance.yahoo Decider inference: the setup is a recovery trade, not confirmation of a new long-term uptrend.

The independent completed October 6, 13:15–14:15 base has a $404.040009 low. The final research quote at 14:40 and the independent publication bars through 14:55 preserved it. The writer's additional completed 14:55–15:00 and 15:00–15:05 bars had lows of $405.3284 and $405.6601, respectively; the 15:07 quote also remained above the base. Phase VWAP through the latest completed bar was $405.3606, slightly above that quote. These observations support intact local structure, not a new stop or an event-anchored VWAP claim. finance.yahoo

Do not mistake a recap for a fresh catalyst. The clinical meta-analysis first appeared September 2; the issuer's September 8 recap did not restart its disclosure clock. The research did not establish new orders, reimbursement, a revenue-guidance increase or quantifiable seven-day recurring cash from it. pubmed.ncbi.nisrg.intuitiv The selection therefore relies on current momentum with financial resilience, not assumed clinical monetization before October 13.

What is already priced in versus still required: the 16.08% recovery is historical, not available future upside. At the frozen research entry, first resistance $409.29 is approximately 1.04% away, the next obstacle is $414.20, and T1 $416.51 is 2.82% away. The actual profit barrier requires 5.08% further appreciation. Those levels derive from observed price structure; the decider's probabilities of clearing them are estimates. finance.yahoo Analysis: already-realized strength supports persistence but also raises reversal risk; it cannot be counted twice as incremental economics.

Participation is the principal contradiction. October 5 volume was about 0.695 times its 20-day mean, and the final research's simple intraday volume pace was approximately 0.36 times typical. Such linear pacing does not adjust for the normal intraday volume curve. finance.yahoo The decider retained only a modest +1.10% conditional time-exit mean and tested a zero-drift adverse case rather than extrapolating the prior rally.

Business And Market Context

Economics that support resilience—not a new weekly earnings catalyst

Intuitive's da Vinci surgical systems and Ion diagnostic platform are supported by instruments, accessories and services. finance.yahoo In the July 16, 2026 Q2 disclosure, revenue was $2.8923 billion, including $1.7349 billion of instruments/accessories and $472.4 million of services; the corresponding year-earlier category figures were $1.4741 billion and $391.2 million. Worldwide da Vinci procedures grew 15%, Ion procedures 36%, and the da Vinci installed base reached 11,710, up 12%. isrg.intuitiv

Calculation from those reported categories: instruments/accessories plus services represented approximately 76.32% of Q2 revenue and grew 18.34% year over year. isrg.intuitiv Investment inference: recurring usage economics are more relevant to resilience than a product headline alone, but these July results are not newly disclosed October cash. No current earnings-consensus revision series was verified.

The same release maintained a 13.5%–15.5% procedure-growth outlook, 68%–69% gross-margin range and 11%–13% operating-expense growth outlook. Its $2.80 non-GAAP quarterly EPS included a $0.08 tariff refund. isrg.intuitiv Analyst normalization: subtracting only that item gives $2.72, not a fully normalized earnings measure or a fresh recurring upgrade.

At June 30, cash, equivalents and investments totaled $8.6255 billion; current assets/liabilities were $9.5427 billion/$1.9229 billion. First-half operating cash flow was $1.9729 billion and capital expenditure $215.9 million. sec.gov Calculations: current ratio approximately 4.96; operating cash flow less capex $1.7570 billion. The latter excludes $528.2 million of acquisition cash and is not comprehensive all-in free cash flow. sec.gov Decider assessment: this supports liquidity resilience, not a guarantee against operating or legal losses.

The latest October 6, 15:07 provider profile showed approximately 46.47× trailing earnings and 33.50× forward earnings. The forward estimate period and accounting basis were not independently reconciled. finance.yahoo Analysis: valuation is premium, not a downside floor; the seven-day target is technical structure, not an annual consensus valuation target.

Market and matched-horizon benchmark

At the authoritative freeze, SPY/QQQ were above completed trend averages, while RSP/IWM participation was weaker. The official October 5 Treasury context was 4.84% for two years and 5.31% for ten years, not an intraday October 6 rate observation. finance.yahoofinance.yahoofinance.yahoohome.treasury Decider interpretation: selective momentum remains possible; the supplied evidence does not establish a broad crash/bear regime. Full exchange advance/decline counts and comprehensive sector breadth were unavailable.

The SPY research quote was $779.780029 at October 6, 14:40 ET, synchronized with ISRG/VST; its independent publication observation was $780.140015 at 14:55 ET. finance.yaho Neither quote is itself forecast evidence. The decider's unchanged, uncalibrated seven-day forecast is:

Decider SPY scenario	Assumed probability	Assumed price return
Continuation	40%	+1.75%
Range	35%	+0.25%
Pullback	20%	−1.50%
Shock	5%	−3.75%

Calculation: weighted price return +0.30%, plus zero entitled dividend, less 0.10 percentage points friction = +0.20% net. The distribution assumptions express the decider's judgment based on trend, breadth and rates; there is no fitted reference class. SPY's September 18 and December 18 ex-dates place no entitlement inside October 6–13; an October 30 payment does not entitle a new October 6 buyer. ssga

The checked calendar places October 7 Fed minutes, October 8 claims, October 9 Michigan sentiment and October 13 existing-home sales inside the interval; October 14 CPI is outside. October 6's 15:30 Cook discussion is ordinary macro risk. federalreseroui.doleta.gsca.isr.umicnar.realtorbls.govfederalreser Broad macro exposure is a risk input, not a company-specific binary exclusion. Equities remain open October 12 despite the distinct recommended bond-market closure. nysesifma.org

Factor Stack

Factor	Source-reported observation or research limitation	Decider assessment
Catalyst/news	Study first disclosed September 2; no verified new weekly operating raise. pubmed.ncbi.nisrg.intuitiv	Momentum, not fresh-news cash repricing.
Growth/profitability	July Q2 procedure growth and recurring categories; maintained outlook; $0.08 tariff-refund EPS benefit. isrg.intuitiv	Supports resilience; do not annualize a refund or borrow October 20 earnings.
Financial health	June 30 liquid assets and positive first-half operating cash generation. sec.gov	No observed solvency failure; not immunity to litigation or competition.
Valuation	October 6, 15:07 provider P/E approximately 46.47× trailing/33.50× forward; forward basis unreconciled. finance.yahoo	Premium valuation raises duration/reversal risk; not a target anchor.
Momentum/relative strength	Completed SMA20/50 $389.364/$381.418; below SMA200 $446.4751; strong matched-period sector/market excess, weak volume. finance.yahoo	Strongest verified positive factor, with fragile participation.
Social/user/expert confirmation	Small Reddit sample: September-indexed moat/training/valuation debate and October 6 repair/antitrust concern. The September discussion's rendered relative-time label conflicts with its indexed date. redditreddit	Mixed, nonrepresentative opinion—not measured demand, positioning or a verified expert consensus.
EPS revisions	No current consensus-revision panel verified. The cited September 8 BTIG reiteration was not a new earnings upgrade. finance.yaho	No positive revision factor is credited.

No verified X, YouTube or Threads findings, representative user survey or fresh search-interest trend were supplied. Community claims of medical expertise were not independently verified; social anecdotes are not operating facts. The decider's Low confidence is descriptive and does not change eligibility, ranking or the stop method.

Investment Thesis

Evidence-to-forecast bridge

Decider judgment: stock-specific recovery plus an intact contemporary base supports a modest continuation toward resistance within seven days. Historical liquidity and recurring economics make that judgment more plausible; they do not provide incremental October revenue. The strongest contradiction is weak participation, compounded by premium valuation, reversal noise and no fresh operating estimate raise.

The preserved T1 of $416.51 is the September 28 high. It remains distinct from $409.29 first resistance and the $414.20 intervening obstacle. finance.yahoo At the original entry, the actual full-position profit barrier is calculated as:

$405.075012 + 1.8 × ($416.51 − $405.075012) = $425.657990, a 5.081276% return.

That additional travel is about 1.81 completed ATR14 units using the research $11.36 ATR; ATR describes price dispersion, not the uncertainty in the mean or calibrated barrier odds. finance.yahoo Decider assumption: 20% probability of an actual barrier-caused exit before stop or maturity. Its illustrative 50% resistance-clearance × 40% subsequent barrier-reach decomposition is subjective, not measured frequency. T1 touching alone does not count as success for that branch.

Mutually exclusive research policy exit	Decider probability	Decider conditional outcome before friction
Actual full-position profit-barrier exit	20%	+5.081276%, calculated at $425.657990
Realized stop exit	20%	−5.079309%, calculated at estimated $384.50
Neither earlier exit; horizon exit	60%	+1.10%, assumed; implied endpoint $409.530837

All probabilities, conditional means and the $384.50 stop-exit estimate are uncalibrated decider estimates, not provider forecasts. The $387.50 authored stop sits $1.61 below the completed October 5 daily low of $389.11; that daily low governs rather than the inconsistent five-minute low. finance.yahoo The additional $3 downside to the assumed actual exit accounts for averaging/confirmation and gaps, without guaranteeing adequacy.

Calculation from frozen assumptions:

EV = 0.20×5.081276 + 0.20×(−5.079309) + 0.60×1.10 − 0.10 = +0.560393%.

Subtracting the estimated +0.20% SPY mean gives +0.360393 percentage points expected excess; subtracting the decider's 1.65-point uncertainty gives −1.289607 points. Research raw T1 reward/authored-risk is 0.650639, actual-barrier reward/authored-risk 1.171150, and Expected R 0.129161. These are diagnostics, not source-reported returns or a confidence interval. The qualifying gate is the supported positive net absolute mean before uncertainty—not positive excess, a confidence score or a raw reward/risk threshold.

Best available alternative and coherent adverse review

VST is rank 2 among confirmed actionable forecasts. Its October 5 conditional DOE financing details followed the October 2 report; neither the up-to-$4.2 billion financing ceiling nor planned 433 MW represents weekly operating cash. energy.gov Its older $158.454697 completed base survived, while the newer $160/$160.13 shelf failed. finance.yaho These facts caused the decider to repair the conditional time return from +1.20% to +0.80%, after separately isolating quote drift—not to invent a hard rejection or blanket probability haircut.

VST's $167.80 T1 implies a $174.335996 actual barrier, approximately 9.21% above its $159.630005 research entry; this is much farther than its $160.94 first obstacle. Those are calculations from its preserved inputs. Its 12/35/53% profit/stop/time assumptions and $154.50 delayed-stop estimate yield +0.304716% net, +0.104716 points SPY excess, and −1.395284 points after uncertainty. ISRG's research ranking lead is only 0.105677 points. VST's fresher headline is a positive comparison factor; existing CEG exposure adds portfolio overlap under the supplied runtime context, not a factual correlation estimate or veto.

The pair stress holds entry, authored stop, T1, seven-day horizon and policy fixed. Decider adverse overrides: ISRG 12/30/58%, stop exit $383.50, time return 0%, friction 0.10%; VST 10/40/50%, stop exit $153, time +0.50%, friction 0.15%. Both use SPY −0.575% net, from adverse 25/25/40/10% weights on unchanged SPY endpoints. Weak participation, missing operating raises, rate/breadth pressure and VST's failed newer shelf motivate the challenge; the numerical overrides themselves are analyst estimates. finance.yahoofinance.yahoenergy.govhome.treasury

Research calculation	ISRG	VST	SPY matched buy-and-hold
Base net absolute return	+0.5604%	+0.3047%	+0.2000%
Base net excess	+0.3604 pp	+0.1047 pp	0
Declared stock uncertainty	1.65 pp	1.50 pp	Not a stock-policy rank
Excess less uncertainty	−1.2896 pp	−1.3953 pp	Not applicable
Adverse net absolute return	−1.0881%	−0.6401%	−0.5750%
Adverse net excess	−0.5131 pp	−0.0651 pp	0
Minimum uncertainty covering supported mean deterioration	1.6485 pp	0.9448 pp	Not applicable
Declared uncertainty covers supported stress	Yes	Yes	Not applicable
Profit-to-stop probability-shift headroom	5.515431 pp	2.452071 pp	Not applicable
Profit-to-time probability-shift headroom	14.075890 pp	3.621970 pp	Not applicable

Headroom is sensitivity to reallocating probability until the base absolute mean reaches zero, not calibrated odds. ISRG's uncertainty barely covers the supported 1.6485-point deterioration. VST has the better adverse outcome, but the mandated base/uncertainty ranking favors ISRG. Negative stress and uncertainty-adjusted returns are disclosed, not substituted for the positive-base gate. The stress loss is not deducted again; ATR/VIX dispersion is not independently stacked as a mean-error haircut.

Publication observations and full-gate comparison

Independent publication certification was recorded October 6 at 15:02:58 ET, after the 14:55 pair quotes and bounded event/support checks. The latest writer-only ISRG refresh below does not change the research freeze, odds, target or benchmark forecast, and is not a new synchronized all-candidate ranking.

Calculation with unchanged assumptions	Research ISRG, 14:40	Certified publication ISRG, 14:55	Latest ISRG diagnostic, 15:07
Observed quote	$405.075012	$405.387512	$405.239990
Derived actual profit barrier	$425.657990	$425.407990	$425.526008
Derived authored stop distance	4.338706%	4.412448%	4.377650%
Expected net absolute return	+0.560393%	+0.517224%	+0.537595%
Expected SPY excess	+0.360393 pp	+0.317224 pp	+0.337595 pp
Excess less 1.65 pp uncertainty	−1.289607 pp	−1.332776 pp	−1.312405 pp

Quote observations: finance.yahoo. All other cells are calculations using the decider's unchanged assumptions. At the latest quote, the retained stress calculates −1.108705% absolute/−0.533705 points excess, and 1.646300 points base-to-stress deterioration, still within 1.65. No selected support breach or positive-gate failure was observed.

The last synchronized independent publication comparison had VST at $159.940002, 14:55 ET, producing +0.195051% net and −1.504949 points uncertainty-adjusted excess. finance.yaho ISRG's certified lead was 0.172174 points, still fragile. VST's slightly negative publication SPY excess did not invalidate its positive absolute mean. The newer selected-only quote is not presented as a contemporaneous quote for VST or SPY.

All ten researched finalists were accounted for. The following preserves the research-freeze comparison; conditional arithmetic is not eligibility certification:

Symbol	Full-gate rank where assigned	Research expected net return	Status / reason
ISRG	1	+0.560393%	Selected; supported positive base
VST	2	+0.304716%	Best confirmed alternative; lower adjusted excess
STLD	3	−0.062650%	Complete actionable forecast fails absolute gate
LUV	4	−0.500929%	Complete actionable forecast fails absolute gate
AMAT	5	−0.011376%	Complete actionable forecast fails absolute gate
MPC	6	−0.189008%	Complete actionable forecast fails absolute gate
DELL	Unassigned	+0.336956%, provisional	Mandatory-gap applicability/base and legal agenda unresolved
COIN	Unassigned	+0.345779%, provisional	Mandatory-gap applicability/base and legal agenda unresolved
MRVL	Unassigned	Not estimated	Evidenced mandatory-trigger/broken-support exclusion
PTC	Unassigned	Not estimated	Evidenced unmet mandatory trigger; not an asserted support breach

These are decider calculations/decisions, not reported market forecasts. STLD's September 17 guide and peer spot-price strength, LUV's October 6 booking feature, AMAT's October 6 research collaboration, and MPC's October 5 product-spread evidence did not supply enough supported residual net return in their complete scenarios. The five nonselected complete scenarios and their full-gate ranks are preserved in frontmatter. steelmarketuinvestors.soir.appliedmaeia.gov

COIN/DELL were not promoted merely because provisional arithmetic was positive; even favorable eligibility resolution at retained inputs ranked them below ISRG. MRVL's previously identified $287.529999 support broke, and the final research price was below its $288.880657 regular proxy; PTC lacked a qualifying above-anchor base, while its next-session route was still incomplete. Their exact anchor/coverage qualifications persist and no probability forecasts are fabricated. finance.yahofinance.yahofinance.yahofinance.yaho A supported initial pick meant no additional generation round was required; this is not an N/A audit or an all-ten-actionable certification.

Risks And Thesis Breakers

Weak follow-through and resistance rejection. The $404.04 local base is corroboration, not the executable $387.50 stop. An observed base breach or sustained inability to clear $409.29 would undermine the decider's +1.10% residual-drift/20% profit assumptions and require upstream reassessment, not a writer-invented automatic exit. The 15:07 check found no such base breach. finance.yahoo
A larger move is required than T1 suggests. The 20% branch requires the actual 1.8-times-T1-gain barrier, after clearing multiple obstacles. The decider's probability decomposition is not fitted; a relatively small profit-to-stop shift removes the positive expected mean. Premium valuation and thin volume make this a meaningful risk, not a high-conviction projection. finance.yahoo
Delayed exits and overnight gaps. The trailing-average/confirmation rules can postpone the stop beyond the visible threshold and today's closing session. The modeled $384.50 actual stop exit is not a worst-case bound. Both ordinary and hard-loss exits may fill materially lower; 0.1% adverse slippage is a modeling convention, not an execution guarantee.
Operating and legal risks. The maintained outlook is not an October upgrade. Existing litigation remains material: the August 13 appellate antitrust reversal/remand was not a new October 6 ruling, and unscheduled developments are not universally cleared. isrg.intuitivcdn.ca9.uscosec.gov An identified imminent thesis-dependent company binary, adverse operating update or liquidity deterioration would require a decision repair.
Event window is bounded, not exhaustive. The issuer's undated calendar, rechecked October 6, lists the Q3 call October 20, 1:30 PM PDT / 4:30 PM ET, outside the seven-day horizon. investor.int The independent 14:56–14:59 checks identified no new scheduled thesis-dependent binary before the next executable stop window, but did not establish comprehensive legal-docket clearance. No October 20 earnings payoff is credited to this trade.
Historical anchor and volume limitations. The September 2 regular-open date-anchor VWAP of $384.2281 is not an exact study-publication-clock anchor. Completed intraday shares covered 75.5594% of daily volume; conditional missing-volume bounds were $383.0139–$385.7558 under comparable-volume/same-day-range assumptions. The later minute audit missed 14:25, covered only by completed five-minute OHLC—not recovered minute data. These are qualified diagnostics, not universal auction certification. finance.yahoo
Forecast and research-access limitations. No fitted probability reference class, fresh consensus-revision dataset, complete exchange breadth, current intraday Treasury observation, comprehensive legal agenda, numerical portfolio correlations or recent-closed-position list was supplied. The challenged search service remained unavailable; independent sources supplied the bounded checks without treating access failure as market weakness. Social coverage is small and mixed. None of these limitations licenses stronger odds or an extended horizon.

The research did not establish a new catalyst-driven roughly-10% or 2.5-times-pre-event-ATR move for ISRG. The September 2 range was approximately 1.3277 times pre-event ATR; October 5's recovery range was 1.7196 times its pre-session ATR. finance.yahoopubmed.ncbi.n Decider judgment: the mandatory post-catalyst extension route was not triggered for this independently supported momentum thesis. The later base is corroboration, not retrospective certification of the unknown study clock.

Investment Recommendation

Retain ISRG as the single immediate-entry Momentum recommendation, Low descriptive confidence, with the original research quote and scenario assumptions intact. The latest successful observation is $405.239990 at October 6, 15:07 ET; it is an observation, not an order or a fill. finance.yahoo The unchanged-assumption diagnostic remains positive before uncertainty, but expected excess is small and uncertainty-adjusted excess is negative. This is a fragile seven-day allocation, not a long-term valuation endorsement or guaranteed benchmark outperformance.

Sizing—supplied runtime policy: one slot is 1/12 of the fund, approximately 8.33%. Use one slot, one active lot for this symbol; do not invent leverage, scaling or additional lots. ISRG is absent from the supplied active-public list. Healthcare was 10.30% of the supplied portfolio snapshot, so this adds sector exposure rather than eliminating it. Those are frozen account-context inputs, not independently fetched broker balances; recent closures and numerical correlations remain unknown.

Fixed full-position exit policy:

Authored stop $387.50: the trailing 60-minute average must remain below it for 120 minutes. It is not an immediate tick-stop. The decider estimates a conditional actual stop exit of $384.50 before friction, allowing delay/gaps, without promising that price.
Hard-loss condition: a 15% loss requires 10 minutes of confirmation. Its research-entry threshold is calculated at $344.313760; the latest-quote diagnostic is $344.453992. Neither guarantees an exact exit. The updater's overnight-counter implementation was not established by research.
Profit exit: sell the full position at 1.8 times the T1 percentage gain, not at T1. T1 remains $416.51; research-entry barrier $425.657990, latest-quote diagnostic barrier $425.526008. Do not mix one entry's barrier with another entry's forecast. No discretionary trims or trails are added.
Time exit: the preserved research interval is October 6, 14:40 ET → October 13, 14:40 ET, exactly 604,800 seconds. Its first liquid regular-session exit window is October 13, 14:40–16:00 ET. nyse This is the research-state timestamp, not a retroactive fill. Under the supplied runtime contract, any actual recorded entry must mature exactly seven calendar days later, with the first liquid exit at or after that maturity; publication delay does not permit a longer investment horizon.
Friction and cash: model 0.1% adverse exit slippage once. Early full-position exit proceeds remain cash through the scheduled maturity with no modeled yield. SPY is compared as buy-and-hold over that same interval. No commission, dividend, horizon extension or post-exit reinvestment benefit is invented.

Publication eligibility: an independent constituent-table fetch at October 6, 14:56:08 ET confirmed ISRG, and the writer's October 6 recheck again found it in the current table. The source is an undated secondary list, not index-provider certification. en.wikipedia The fresh issuer-calendar and completed-bar checks preserve the bounded event/support evidence. A later material quote, support, event or active-position change requires upstream decision repair—not a substitute selection or fabricated N/A.

The separate VOO-versus-Robinhood-Gold-cash review is not applicable, because the authoritative decision is a stock pick, not a complete audited stock N/A. No cash APY or allocation choice is asserted. Analysis only; no trade has been placed.